Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) develops, manufactures and markets a family of tissue care products to treat infections and, through a separate mechanism of action, enhance healing while reducing the need for antibiotics. Oculus Innovative Sciences, Inc. witnessed volume of 307,586.00 shares during last trade however it holds an average trading capacity of 93,993.00 shares.